high triglycerides and glp-1 Study: Agonists Safe for Triglycerides, No Pancreatitis Glucagon-like peptide-1 receptor: mechanisms and

Contraindications: Not recommended for individuals with a history of Medullary Thyroid Cancer, pancreatitis, or those who are pregnant

No, there is no official recommendation for routine supplementation for all GLP-1 users

Choosing between semaglutide and tirzepatide requires a clinical conversation that takes into account your current weight, medical history, metabolic markers, any existing conditions like insulin resistance or type 2 diabetes, your response to previous weight loss attempts, and your insurance coverage

Post-treatment weight regain following discontinuation of GLP-1 receptor agonist therapy

This development marks an important advance in the pharmacological management of obesity-related OSAS

Long-term GLP-1 use also means that nutritional needs evolve over time